Thirty-two month follow-up of successful treatment of choroidal neovascularization from angioid streaks with intravitreal bevacizumab

Jaclyn L. Kovach, Stephen G. Schwartz, Marcela Hickey, Carmen A. Puliafito

Research output: Contribution to journalArticle

15 Scopus citations


A patient presented with subfoveal choroidal neovascularization associated with angioid streaks and was treated with three intravitreal injections of off-label bevacizumab (1.25 mg) in the right eye. Visual acuity improved from 20/70 to 20/20 and remained at this level for 32 months. In certain patients with choroidal neovascularization from angioid streaks, intravitreal be-vacizumab may produce normalization of visual acuity and macular anatomy for an extended period of time.

Original languageEnglish (US)
Pages (from-to)77-79
Number of pages3
JournalOphthalmic Surgery Lasers and Imaging
Issue number1
StatePublished - Jan 1 2009


ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Cite this